BioDtech, Inc.
BioDtech Announces the Release of EndoPrep™
Published in Cardiovascular Week, January 26th, 2009
BioDtech, Inc. (BDTI) an emerging life science company, announced the release of EndoPrep™, the first product designed for the safety of genetically engineered and protein drugs. EndoPrep™ allows for the more accurate detection of a toxin associated with the production of antibodies, recombinant proteins and synthetic peptides which are the basis for new cancer, cardiovascular, neurological, infectious and metabolic diseases. The toxin is masked by these drugs in the current FDA approved methods for detection. EndoPrep™ removes the drug allowing the toxin to be exposed and detected by standard assays.
"This unique product can be used with other standard assays for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2009-01-26)
More Articles from Cardiovascular Week
- University of Calgary
Research finds older women who are more physically fit have better cognitive function - University of Pennsylvania School of Medicine
Penn study: Chances of surviving cardiac arrest depend on where patients are treated - Abdominal Aortic Aneurysm
Studies by R. Mofidi and co-authors describe new findings in abdominal aortic aneurysm - Adverse Drug Reactions
Studies from A.P. Maggioni and colleagues provide new data on adverse drug reactions - Alcoholism
New findings in alcoholism described by A. Picardi and co-researchers - Angiogenesis
Research findings from University of Bristol update understanding of angiogenesis - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
